A year into the COVID-19 pandemic, vaccines are a reality—and now we face the logistical and medical complications of inoculating a vast population while infection rages and the virus mutates. We asked Yale SOM’s Dr. Howard Forman, a public authority on the pandemic, for an update.

Despite being easy and inexpensive to treat, a group of common bacterial and parasitic infections kill hundreds of thousands of people in tropical countries each year. In a new paper, Yale SOM’s Teresa Chahine and her co-authors map the complex system of stakeholders surrounding the diseases and identify key leverage points for making progress. 

A new federal law prevents patients from being billed by out-of-network doctors after being treated in an in-network hospital. We asked Prof. Fiona Scott Morton, whose research helped bring the practice to light, what the new law will mean for patients and healthcare costs.

Nandish Poluru ’13 discusses the pharmaceutical industry’s unprecedented cooperative efforts to treat and prevent COVID-19.

Pfizer’s announcement that its experimental COVID-19 vaccine appears to be more than 90% effective has provided hope for relief from the increasingly calamitous onslaught of the virus. We asked Yale SOM’s Dr. Howard Forman about next steps.

Dr. Suzanne Lagarde ’14 describes how her federally qualified nonprofit health center is both adapting and expanding to meet new needs in an underserved community.